Description

6-Iodo-7-Methyl-2,3-Dihydro-1H-Pyrido-[2,3-B][1,4]Oxazine is a heterocyclic organic compound featuring a fused pyrido-oxazine core structure, which is a key intermediate in advanced pharmaceutical synthesis. This compound matters for its role as a versatile building block in the development of novel active pharmaceutical ingredients (APIs), particularly in medicinal chemistry research targeting complex therapeutic areas. Pharmaceutical R&D laboratories and fine chemical manufacturers need this high-purity intermediate to facilitate the synthesis of potential drug candidates with specific biological activity.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug molecules, especially in oncology and central nervous system (CNS) research.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Organic Synthesis Building Block: The iodine substituent makes it a valuable substrate for further functionalization via cross-coupling reactions (e.g., Suzuki, Sonogashira).
• Chemical Reference Standard: Serves as an analytical standard for quality control and method development in API manufacturing.
• Agrochemical Research: Potential intermediate in the development of new crop protection agents and pesticides.
• Material Science Exploration: Investigated as a monomer or precursor for specialty polymers and advanced organic materials.

Basic Information

Product Name	6-Iodo-7-Methyl-2,3-Dihydro-1H-Pyrido-[2,3-B][1,4]Oxazine
CAS No.	1261365-45-0
Molecular Formula	C8H9IN2O
Molecular Weight	276.08 g/mol
Synonyms	6-Iodo-7-methyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine; 7-Methyl-6-iodo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine; 1H-Pyrido[2,3-b][1,4]oxazine, 6-iodo-2,3-dihydro-7-methyl-; 6-Iodo-7-methyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine; Pyrido-oxazine iodo derivative; CAS 1261365-45-0
EINECS	Contact for details

Quality Control

Our 6-Iodo-7-Methyl-2,3-Dihydro-1H-Pyrido-[2,3-B][1,4]Oxazine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The product is light-sensitive (store away from light). Keep the container tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.